NFID Secretary-Treasurer Kevin M. Rooney is senior vice president of corporate development and strategy for NervGen Pharma, a publicly traded, development stage biotech company focused on developing treatments to enable nervous system repair in the settings of traumatic injury and disease. Throughout his career, he has had an extensive track record of successful leadership roles in the biopharmaceutical industry, and has also run a successful consulting firm for over 15 years.